CDXC - ChromaDex Corporation (CDXC) Q4 2023 Earnings Call Transcript

2024-03-06 23:11:06 ET

ChromaDex Corporation (CDXC)

Q4 2023 Earnings Conference Call

March 06, 2024, 04:30 PM ET

Company Participants

Kendall Knysch - Director, Media Relations

Rob Fried - CEO

Brianna Gerber - CFO

Andrew Shao - Senior Vice President of Scientific and Regulatory Affairs

Conference Call Participants

Jeffrey Cohen - Ladenburg Thalmann

Mitchell Pinheiro - Sturdivant & Company

Sean McGowan - ROTH MKM

Matthew Dhane - Tieton Capital Management

Presentation

Operator

Ladies and gentlemen, thank you for standing by and welcome to ChromaDex Corporation's Fourth Quarter 2023 Earnings Conference Call. My name is Mandeep and I will be the conference operator today. At this time, all participants are in a listen-only mode and as a reminder, this conference call is being recorded. This afternoon, ChromaDex issued a news release announcing the company's financial results for the fourth quarter of 2023. If you have not reviewed this information, both are available within the investor relations section of ChromaDex's website at www. ChromaDex .com .

I would now like to turn the conference over to Kendall Knysch, Head of Public Relations and partnerships. Please go ahead Ms. Knysch.

Kendall Knysch

Thank you. Good afternoon and welcome to ChromaDex Corporation's fourth quarter 2023 results investor call. With us today are ChromaDex's Chief Executive Officer, Rob Fried, Chief Financial Officer, Brianna Gerber, and Senior Vice President of Scientific and Regulatory Affairs, Dr. Andrew Shao, who will join the call for Q&A.

Today's conference call may include forward-looking statements, including statements related to ChromaDex's research and development and clinical trial plans and the timing and results of such trials, the timing of future regulatory filings, the expansion of the sale of Tru Niagen in new markets, business development opportunities, future financial results, cash needs, operating performance, investor interest, and business prospects and opportunities, as well as anticipated results of operations.

Forward-looking statements represent only the company's estimates on the date of this conference call and are not intended to give any assurance as to actual future results. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties....

For further details see: